Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance. Issue 9 (September 2016)
- Record Type:
- Journal Article
- Title:
- Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance. Issue 9 (September 2016)
- Main Title:
- Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance
- Authors:
- Bonnington, Sue
Bradshaw, Lynne
Cooper, Debbie
Elliott, Emma
Herbert, Pippa
Holding, Peter
Howson, Joanne
Jones, Mandy
Lennon, Teresa
Lyons, Norma
Moody, Hilary
Plumb, Claire
O'Sullivan, Tricia
Salter, Liz
Tidball, Sarah
Thompson, Pauline
Adam, Tonia
Askew, Sarah
Atkinson, Sharon
Baynes, Tim
Blaikie, Jan
Brain, Carole
Breen, Viv
Brunt, Sarah
Bryne, Sean
Bythem, Jo
Clarke, Jenny
Cloete, Jenny
Dark, Susan
Davis, Gill
De La Rue, Rachael
Denizot, Jane
Dewhurst, Elspeth
Dimes, Anna
Dixon, Nicola
Ebbs, Penny
Emmerson, Ingrid
Ferguson, Jill
Gadd, Ali
Geoghegan, Lisa
Grant, Alison
Grant, Collette
Gray, Catherine
Godfrey, Rosemary
Goodwin, Louise
Hall, Susie
Hart, Liz
Harvey, Andrew
Hoult, Chloe
Hawkins, Sarah
Holling, Sharon
Innes, Alastair
Kilner, Sue
Marshall, Fiona
Mellen, Louise
Moore, Andrea
Napier, Sally
Needham, Julie
Pearse, Kevin
Pisa, Anna
Rees, Mark
Richards, Elliw
Robson, Lindsay
Roxburgh, Janet
Samuel, Nikki
Sharkey, Irene
Slater, Michael
Smith, Donna
Taggart, Pippa
Taylor, Helen
Taylor, Vicky
Thomas, Ayesha
Tomkies, Briony
Trewick, Nicola
Ward, Claire
Walker, Christy
Williams, Ayesha
Woodhouse, Colin
Wyber, Elizabeth
Aning, Jonathan
Bollina, Prasad
Catto, Jim
Doble, Andrew
Doherty, Alan
Durkan, Garett
Gillatt, David
Hughes, Owen
Kocklebergh, Roger
Kouparis, Anthony
Kynaston, Howard
Leung, Hing
Mariappan, Param
McNeill, Alan
Paez, Edgar
Paul, Alan
Persad, Raj
Powell, Philip
Prescott, Stephen
Rosario, Derek
Rowe, Edward
Schwaibold, Hartwig
Tulloch, David
Wallace, Mike
Bahl, Amit
Benson, Richard
Beresford, Mark
Ferguson, Catherine
Graham, John
Herbert, Chris
Howard, Graham
James, Nick
Law, Alastair
Loughrey, Carmel
Mason, Malcolm
McClaren, Duncan
Patterson, Helen
Pedley, Ian
Robinson, Angus
Russell, Simon
Staffurth, John
Symonds, Paul
Thanvi, Narottam
Vasanthan, Subramaniam
Wilson, Paula
Appleby, Helen
Ash, Dominic
Aston, Dean
Bolton, Steven
Chalmers, Graham
Conway, John
Early, Nick
Geater, Tony
Goddall, Lynda
Heymann, Claire
Hicks, Deborah
Jones, Liza
Lamb, Susan
Lambert, Geoff
Lawrence, Gill
Lewis, Geraint
Lilley, John
MacLeod, Aileen
Massey, Pauline
McQueen, Alison
Moore, Rollo
Penketh, Lynda
Potterton, Janet
Roberts, Neil
Showler, Helen
Slade, Stephen
Steele, Alasdair
Swinscoe, James
Tiffany, Marie
Townley, John
Treeby, Jo
Wilkinson, Joyce
Williams, Lorraine
Wills, Lucy
Woodley, Owain
Yarrow, Sue
Bhattarai, Selina
Deshmukh, Neeta
Dormer, John
Fernando, Malee
Goepel, John
Griffiths, David
Grigor, Ken
Mayer, Nick
Oxley, Jon
Robinson, Mary
Varma, Murali
Warren, Anne
Brindle, Lucy
Davis, Michael
Dedman, Dan
Down, Elizabeth
Khazragui, Hanan
Metcalfe, Chris
Noble, Sian
Peters, Tim
Taylor, Hilary
Turner, Emma
Wade, Julia
Walsh, Eleanor
Baker, Susan
Bellis-Sheldon, Elizabeth
Bougard, Chantal
Bowtell, Joanne
Brewer, Catherine
Burton, Chris
Charlton, Jennie
Christoforou, Nicholas
Clark, Rebecca
Coull, Susan
Croker, Christine
Currer, Rosemary
Daisey, Claire
Delaney, Gill
Donohue, Rose
Drew, Jane
Farmer, Rebecca
Fry, Susan
Haddow, Jean
Hale, Alex
Halpin, Susan
Harris, Belle
Hattrick, Barbara
Holmes, Sharon
Hunt, Helen
Jackson, Vicky
Johnson, Donna
Le Butt, Mandy
Leworthy, Jo
Liddiatt, Tanya
Martin, Alex
Mauree, Jainee
Moore, Susan
Moulam, Gill
Mutch, Jackie
Parker, Kathleen
Pawsey, Christopher
Purdie, Michelle
Robson, Teresa
Smith, Lynne
Stenton, Carole
Steuart-Feilding, Tom
Sully, Chris
Sutton, Caroline
Torrington, Carol
Wilkins, Zoe
Williams, Sharon
Wilson, Andrea
Grant, Adrian
Roberts, Ian
Ashby, Deborah
Cowan, Richard
Fayers, Peter
Mellon, Killian
N'Dow, James
O'Brien, Tim
Sokhal, Michael
Baum, Michael
Adolfson, Jan
Albertsen, Peter
Dearnaley, David
Schroeder, Fritz
Roberts, Tracy
Zietman, Anthony
Mason, M.D.
Moore, R.
Jones, G.
Lewis, G.
Donovan, J.L.
Neal, D.E.
Hamdy, F.C.
Lane, J.A.
Staffurth, J.N.
… (more) - Abstract:
- Abstract: Aims: The treatment of prostate cancer has evolved markedly over the last 40 years, including radiotherapy, notably with escalated dose and targeting. However, the optimal treatment for localised disease has not been established in comparative randomised trials. The aim of this article is to describe the history of prostate radiotherapy trials, including their quality assurance processes, and to compare these with the ProtecT trial. Materials and methods: The UK ProtecT randomised trial compares external beam conformal radiotherapy, surgery and active monitoring for clinically localised prostate cancer and will report on the primary outcome (disease-specific mortality) in 2016 following recruitment between 1999 and 2009. The embedded quality assurance programme consists of on-site machine dosimetry at the nine trial centres, a retrospective review of outlining and adherence to dose constraints based on the trial protocol in 54 participants (randomly selected, around 10% of the total randomised to radiotherapy, n = 545). These quality assurance processes and results were compared with prostate radiotherapy trials of a comparable era. Results: There has been an increasingly sophisticated quality assurance programme in UK prostate radiotherapy trials over the last 15 years, reflecting dose escalation and treatment complexity. In ProtecT, machine dosimetry results were comparable between trial centres and with the UK RT01 trial. The outlining review showed that mostAbstract: Aims: The treatment of prostate cancer has evolved markedly over the last 40 years, including radiotherapy, notably with escalated dose and targeting. However, the optimal treatment for localised disease has not been established in comparative randomised trials. The aim of this article is to describe the history of prostate radiotherapy trials, including their quality assurance processes, and to compare these with the ProtecT trial. Materials and methods: The UK ProtecT randomised trial compares external beam conformal radiotherapy, surgery and active monitoring for clinically localised prostate cancer and will report on the primary outcome (disease-specific mortality) in 2016 following recruitment between 1999 and 2009. The embedded quality assurance programme consists of on-site machine dosimetry at the nine trial centres, a retrospective review of outlining and adherence to dose constraints based on the trial protocol in 54 participants (randomly selected, around 10% of the total randomised to radiotherapy, n = 545). These quality assurance processes and results were compared with prostate radiotherapy trials of a comparable era. Results: There has been an increasingly sophisticated quality assurance programme in UK prostate radiotherapy trials over the last 15 years, reflecting dose escalation and treatment complexity. In ProtecT, machine dosimetry results were comparable between trial centres and with the UK RT01 trial. The outlining review showed that most deviations were clinically acceptable, although three (1.4%) may have been of clinical significance and were related to outlining of the prostate. Seminal vesicle outlining varied, possibly due to several prostate trials running concurrently with different protocols. Adherence to dose constraints in ProtecT was considered acceptable, with 80% of randomised participants having two or less deviations and planning target volume coverage was excellent. Conclusion: The ProtecT trial quality assurance results were satisfactory and comparable with trials of its era. Future trials should aim to standardise treatment protocols and quality assurance programmes where possible to reduce complexities for centres involved in multiple trials. Highlights: No randomised evidence defines the optimal treatment for localised prostate cancer. Radiotherapy can be curative for localised disease. Trial quality assurance is necessary with increasing radiotherapy dose and complexity. The ProtecT trial reports on active monitoring, radiotherapy and surgery in 2016. … (more)
- Is Part Of:
- Clinical oncology. Volume 28:Issue 9(2016)
- Journal:
- Clinical oncology
- Issue:
- Volume 28:Issue 9(2016)
- Issue Display:
- Volume 28, Issue 9 (2016)
- Year:
- 2016
- Volume:
- 28
- Issue:
- 9
- Issue Sort Value:
- 2016-0028-0009-0000
- Page Start:
- e92
- Page End:
- e100
- Publication Date:
- 2016-09
- Subjects:
- Prostate cancer -- quality assurance -- radiotherapy -- randomised controlled trials
Oncology -- Periodicals
Tumors -- Periodicals
Cancer -- Treatment -- Periodicals
Radiotherapy -- Periodicals
Neoplasms -- Periodicals
Cancer -- Radiotherapy
Cancer -- Treatment
Oncology
Medical radiology
Radiotherapy
Tumors
Electronic journals
Periodicals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09366555 ↗
http://www.elsevier.com/journal ↗ - DOI:
- 10.1016/j.clon.2016.05.011 ↗
- Languages:
- English
- ISSNs:
- 0936-6555
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.317000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 779.xml